Learn the applications of neoantigen peptides as personalized Cancer Vaccine (PCV), solid tumor immuno-therapy, and the solutions for neoantigen production, through GenScript’s proprietary technologies, for precision immunotherapy development.
12-07-2022 Gracie Chia, Field Application Scientist, GenScript
09-19-2022 Dr. Fengmei Pi, Head of RNA Biology Department, GenScript
In this webinar, Dr. Ming Ni, the CMC Project Manager for ProBio will provide a high-level overview of his experience in dealing with the challenges of plasmid production.
10-27-2021 Dr. Ming Ni, the CMC Project Manager for ProBio
Interactions between tumor cells and the surrounding microenvironment contribute to tumor progression, metastasis and recurrence.
10-04-2021 Dr. Bon-Kyoung Koo, Group Leader, Institute of Molecular Biotechnology of Austrian Academy of Sciences (IMBA), Vienna, Austria
Development and disease are controlled, to a large degree, by regions of genomic DNA called enhancers that encode binding sites for transcription factor proteins. Binding of activators and repressors increase and reduce gene expression levels, respectivel
12-09-2020 Justin Crocker, Ph.D. Group Leader EMBL Heidelberg
In this webinar, we will present a novel capture resin that can be used to capture and purify target proteins via fusion to a 35 amino acid tag.
12-02-2020 David Wood, Ph.D. Professor of Chemical